ArticleBMC medical genomics2023

ATP6V1F is a novel prognostic biomarker and potential immunotherapy target for hepatocellular carcinoma.

Xinyao Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.